Surgery Partners, Inc. (SGRY) stock
SGRYNasdaqServices-General Medical & Surgical Hospitals, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/3011% above fair value
$26.85+0.06 (+0.22%)
Close on Nov 17, 2026Market cap $3.52BP/E –Yield –
Surgery Partners total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Surgery Partners's total debt was $3.75B at Jun 30, 2026. For fiscal 2025 it was $3.70B, up 9.8% from the year before. Over ten years it grew 11.4% a year on average. The highest annual figure on record is $3.70B in fiscal 2025.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.70B | +9.8% |
| FY2024 | Dec 31, 2024 | $3.37B | +21.4% |
| FY2023 | Dec 31, 2023 | $2.78B | +5.8% |
| FY2022 | Dec 31, 2022 | $2.62B | -10.8% |
| FY2021 | Dec 31, 2021 | $2.94B | +2.9% |
| FY2020 | Dec 31, 2020 | $2.86B | +10.7% |
| FY2019 | Dec 31, 2019 | $2.58B | +10.9% |
| FY2018 | Dec 31, 2018 | $2.33B | +6.3% |
| FY2017 | Dec 31, 2017 | $2.19B | +51.8% |
| FY2016 | Dec 31, 2016 | $1.44B | +14.9% |
| FY2015 | Dec 31, 2015 | $1.26B | -7.8% |
| FY2014 | Dec 31, 2014 | $1.36B | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.75B | +4.9% |
| Q1 FY2026 | Mar 31, 2026 | $3.71B | +4.6% |
| Q4 FY2025 | Dec 31, 2025 | $3.70B | +9.8% |
| Q3 FY2025 | Sep 30, 2025 | $3.56B | +11.7% |
| Q2 FY2025 | Jun 30, 2025 | $3.58B | +14.1% |
| Q1 FY2025 | Mar 31, 2025 | $3.55B | +23.7% |
| Q4 FY2024 | Dec 31, 2024 | $3.37B | +21.4% |
| Q3 FY2024 | Sep 30, 2024 | $3.19B | +18.1% |
| Q2 FY2024 | Jun 30, 2024 | $3.13B | +21.9% |
| Q1 FY2024 | Mar 31, 2024 | $2.87B | +10.7% |
| Q4 FY2023 | Dec 31, 2023 | $2.78B | +5.8% |
| Q3 FY2023 | Sep 30, 2023 | $2.70B | -16.1% |
| Q2 FY2023 | Jun 30, 2023 | $2.57B | -16.8% |
| Q1 FY2023 | Mar 31, 2023 | $2.59B | -16.1% |
| Q4 FY2022 | Dec 31, 2022 | $2.62B | -10.8% |
| Q3 FY2022 | Sep 30, 2022 | $3.22B | +12.9% |
| Q2 FY2022 | Jun 30, 2022 | $3.09B | +8.1% |
| Q1 FY2022 | Mar 31, 2022 | $3.09B | +8.5% |
| Q4 FY2021 | Dec 31, 2021 | $2.94B | +2.9% |
| Q3 FY2021 | Sep 30, 2021 | $2.85B | +1.1% |
| Q2 FY2021 | Jun 30, 2021 | $2.86B | +6.3% |
| Q1 FY2021 | Mar 31, 2021 | $2.85B | +6.1% |
| Q4 FY2020 | Dec 31, 2020 | $2.86B | +10.7% |
| Q3 FY2020 | Sep 30, 2020 | $2.82B | +15.0% |
| Q2 FY2020 | Jun 30, 2020 | $2.69B | +9.4% |
| Q1 FY2020 | Mar 31, 2020 | $2.69B | +10.0% |
| Q4 FY2019 | Dec 31, 2019 | $2.58B | +10.9% |
| Q3 FY2019 | Sep 30, 2019 | $2.45B | +13.0% |
| Q2 FY2019 | Jun 30, 2019 | $2.45B | +12.8% |
| Q1 FY2019 | Mar 31, 2019 | $2.44B | +12.2% |
| Q4 FY2018 | Dec 31, 2018 | $2.33B | +6.3% |
| Q3 FY2018 | Sep 30, 2018 | $2.17B | -0.9% |
| Q2 FY2018 | Jun 30, 2018 | $2.18B | +19.2% |
| Q1 FY2018 | Mar 31, 2018 | $2.18B | +52.8% |
| Q4 FY2017 | Dec 31, 2017 | $2.19B | +51.8% |
| Q3 FY2017 | Sep 30, 2017 | $2.19B | +58.1% |
| Q2 FY2017 | Jun 30, 2017 | $1.83B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.42B | – |
| Q4 FY2016 | Dec 31, 2016 | $1.44B | – |
| Q3 FY2016 | Sep 30, 2016 | $1.39B | – |
See a number that looks wrong?